Prostate neoplasm
Information
- Disease name
- Prostate neoplasm
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04030338 | Active, not recruiting | Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer | July 19, 2019 | July 2025 | |
| NCT04019327 | Active, not recruiting | Phase 1/Phase 2 | A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer | July 11, 2019 | July 2027 |
| NCT04045717 | Active, not recruiting | Phase 2 | Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 | April 10, 2020 | February 16, 2032 |
| NCT03493945 | Active, not recruiting | Phase 1/Phase 2 | Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) | May 1, 2018 | December 31, 2024 |
| NCT03344757 | Active, not recruiting | N/A | Health Gatherings - For Your Health After Cancer | October 5, 2017 | August 1, 2024 |
| NCT03241537 | Active, not recruiting | Phase 3 | COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer | January 15, 2016 | December 14, 2026 |
| NCT05276492 | Active, not recruiting | Phase 1 | Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. | January 24, 2023 | November 1, 2025 |
| NCT02380027 | Completed | Phase 3 | PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not? | January 2016 | December 31, 2017 |
| NCT00255125 | Completed | Phase 3 | Role of Soy Supplementation in Prostate Cancer Development | September 2005 | October 2009 |
| NCT00805883 | Completed | Phase 1 | MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy | February 2009 | June 2010 |
| NCT01240551 | Completed | Phase 2 | F-18 Sodium Fluoride in Prostate Cancer | November 30, 2010 | May 31, 2013 |
| NCT00005916 | Completed | Phase 2 | PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer | June 13, 2000 | December 22, 2005 |
| NCT02787434 | Completed | N/A | Addressing Prostate Cancer Information Disparities With eHealth Technology | August 2014 | October 2016 |
| NCT03321149 | Completed | N/A | Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy | July 1, 2015 | October 1, 2016 |
| NCT03458598 | Completed | N/A | Pre-Operative Single Shot Rectus Sheath Block | February 16, 2018 | February 5, 2019 |
| NCT03702439 | Completed | Prostate Cancer Screening Trial Using Imaging | October 10, 2018 | August 22, 2019 | |
| NCT03828838 | Completed | Phase 1/Phase 2 | Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer | July 1, 2018 | November 1, 2019 |
| NCT04376008 | Completed | N/A | A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia | May 1, 2018 | June 1, 2022 |
| NCT04852224 | Completed | Strength, Aging, and Memory in Prostate Cancer | October 1, 2021 | April 26, 2023 | |
| NCT06020287 | Completed | The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach | September 1, 2020 | December 27, 2022 | |
| NCT05373316 | Not yet recruiting | Phase 2 | Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy | December 1, 2022 | July 1, 2029 |
| NCT06430411 | Not yet recruiting | Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | May 31, 2024 | December 31, 2031 | |
| NCT05460312 | Not yet recruiting | Protein Kinase A in Prostate Cancer Tissue. | March 1, 2023 | May 2024 | |
| NCT03822494 | Recruiting | N/A | CyberKnife Dose Escalation Prostate Cancer Trial | July 12, 2018 | July 12, 2028 |
| NCT06223295 | Recruiting | N/A | Effectiveness of Focal Therapy in Men With Prostate Cancer | February 1, 2024 | February 2031 |
| NCT03424850 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy | February 27, 2018 | February 28, 2029 |
| NCT03232164 | Recruiting | Early Phase 1 | PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer | February 2, 2017 | December 2024 |
| NCT04053842 | Recruiting | Phase 2 | Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy | February 4, 2021 | August 31, 2024 |
| NCT04075305 | Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | February 1, 2019 | May 1, 2025 | |
| NCT06292897 | Recruiting | Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression | March 20, 2023 | January 15, 2027 | |
| NCT05422105 | Recruiting | Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient | July 1, 2023 | December 31, 2024 | |
| NCT06315595 | Recruiting | Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion | September 30, 2015 | September 30, 2030 | |
| NCT05252390 | Recruiting | Phase 1/Phase 2 | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors | March 29, 2022 | November 2026 |
| NCT05710380 | Recruiting | N/A | MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy | April 26, 2023 | May 1, 2026 |
| NCT03321864 | Suspended | N/A | Capture of Prostatic Trans-rectal Ultrasound Scans for Research | January 1, 2018 | December 31, 2022 |
| NCT02809690 | Terminated | Phase 1 | 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer | September 12, 2016 | July 21, 2021 |
| NCT04541225 | Terminated | Phase 1 | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | December 8, 2020 | August 31, 2022 |
| NCT03572946 | Unknown status | N/A | Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection | October 9, 2018 | December 2019 |
| NCT01630967 | Unknown status | Phase 2 | Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC) | August 2012 | December 2013 |
| NCT05137561 | Unknown status | N/A | Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate Biopsy | October 25, 2021 | December 31, 2022 |
| NCT04792138 | Unknown status | Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis. | October 23, 2020 | October 2023 | |
| NCT04124107 | Unknown status | N/A | Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection | December 2019 | December 2020 |
| NCT02225262 | Unknown status | N/A | A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors | January 2008 | December 2020 |
| NCT02436122 | Unknown status | Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer | May 2015 | June 2018 | |
| NCT02485665 | Unknown status | N/A | Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence | July 2015 | July 2016 |
| NCT03431753 | Unknown status | N/A | Early and Accurate Detection of Prostate Cancer in General Practice | January 1, 2018 | December 31, 2021 |
| NCT03819751 | Unknown status | N/A | MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection | March 18, 2019 | July 2022 |
| NCT05191017 | Withdrawn | Phase 1/Phase 2 | Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | September 2022 | July 2026 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100787